PPT Slide

BAY 57-1293 in the murine lethal challenge model

Mice were infected intranasally with HSV-2 MS and were treated via oral gavage

once-daily from day 0 to day 4 post infection. Ten animals for each group were used.

Betz et al., Antimicrob. Agents Chemother. 46: 1766-1772 (2002)

Previous slide

Next slide

Back to first slide

View graphic version